2022 Guide to Patient Support Services

2022 Oncology Guide to Patient Support Services

Preview the 2022 Oncology Guide to Patient Support Services. The full guide will be published early 2022.


The Guide to Patient Support Services Index can be sorted by Drug or Company to help you quickly access information about programs offered by pharmaceutical companies and novel cancer drugs approved in 2021. Read More ›

All of us at Oncology Practice Management are delighted to offer the Eighth Annual Oncology Guide to Patient Support Services. At the time of publishing, the Guide represents a comprehensive list of all pharma-sponsored oncology patient support programs. It is our sincere hope the Guide will assist you in enrolling your patients in the programs that can help easy some of the burden of their cancer journey. Read More ›

Patient support services are underutilized. Many times, patients simply are not aware of the services available to them. As providers, we can recommend or “prescribe” support programs to assist patients in their treatment journey. We can also initiate the process by enrolling patients in pharma-sponsored support programs ourselves, so they have the opportunity to realize the benefits from such services. Read More ›

We are pleased to highlight the 2021 FDA-approved oncology drugs and their accompanying patient support programs in the hope of promoting participation and supporting the best possible outcomes. Read More ›

ADC Therapeutics offers the Advancing Patient Support program to assist patients and their healthcare providers access to Zynlonta. Read More ›

Agios Pharmaceuticals offers the myAgios Patient Support Services program to help patients with access and financial assistance when prescribed Tibsovo. Read More ›

Amgen offers assistance to patients through Amgen Assist 360, Amgen FIRST STEP, and the Amgen Safety Net Foundation. Read More ›

Astellas Pharma’s Support Solutions offers access and reimbursement support to help eligible patients overcome challenges to accessing Astellas products. Read More ›

AstraZeneca, through its Access 360 and AZ&Me programs, offers a range of patient assistance to help streamline access and reimbursement for select AstraZeneca medicines. Read More ›

AVEO Pharmaceuticals offers AVEO ACE, a comprehensive program dedicated to providing personalized support to patients and their caregivers while taking Fotivda treatment. Read More ›

Bayer offers drug-specific programs to assist patients with access and resources. Read More ›

BeiGene offers the myBeiGene Patient Support Program to provide appropriate information and assistance to patients taking Brukinsa. Read More ›

Blueprint Medicines offers the YourBlueprint patient support program to provide appropriate information and assistance to patients taking Ayvakit. Read More ›

Boehringer Ingelheim offers the Gilotrif Patient Services program to provide appropriate information and assistance to patients taking Gilotrif. Read More ›

Through its Access Support program, Bristol Myers Squibb (BMS) offers a variety of options to help provide eligible patients access to its oncology medications and reimbursement support services. The program offers benefits reviews, prior authorization assistance, and appeal process support, as well as an easy-to-initiate copay assistance process and information on financial support. The support offered varies based on the patient’s prescribed medication and insurance status. Read More ›

Page 1 of 4

Subscribe to
Oncology Practice Management

Stay up to date with oncology news & updates by subscribing to receive the free OPM print publications or weekly e‑Newsletter.

I'd like to receive: